\begin{tabular}{@{\extracolsep{.3em}}lccD{.}{.}{1.2}D{.}{.}{1.2}D{.}{.}{1.2}D{.}{.}{1.2}D{.}{.}{2.2}D{.}{.}{1.2}D{.}{.}{2.2}}
\toprule
& \multicolumn{9}{c}{Prolactin Response}\\
  \cmidrule(r){2-10}

Drug &\hspace{.2em}& $k$ &\multicolumn{1}{c}{$r$}&\multicolumn{1}{c}{$SE$}&
\multicolumn{1}{c}{$z$}&\multicolumn{1}{c}{$p$}&\multicolumn{2}{c}{95\% $CI$}& \multicolumn{1}{c}{$Q_W$}\\
\midrule
Ipsapirone &  & 4 & -0.06 & 0.15 & -0.39 & 0.59 & [-0.34, & 0.23] & 2.30 \\
d,l-Fenfluramine &  & 25 & -0.10 & 0.05 & -0.97 & 0.04 & [-0.19, & -0.01] & 94.49 \\
d-Fenfluramine &  & 15 & -0.21 & 0.07 & -1.00 & 0.00 & [-0.34, & -0.08] & 14.82 \\
mCPP &  & 9 & -0.10 & 0.09 & -0.81 & 0.25 & [-0.27, & 0.08] & 8.47 \\
Overall &  & 53 & -0.13 & 0.04 & -1.00 & 0.00 & [-0.19, & -0.06] & 124.43 \\

\\

& \multicolumn{9}{c}{Cortisol Response}\\
 \cmidrule(r){2-10}

Ipsapirone &  & 5 & 0.22 & 0.13 & 0.94 & 0.09 & [-0.03, & 0.45] & 10.83 \\
d,l-Fenfluramine &  & 4 & 0.05 & 0.15 & 0.35 & 0.61 & [-0.23, & 0.33] & 5.56 \\
d-Fenfluramine &  & 5 & -0.09 & 0.13 & -0.59 & 0.46 & [-0.33, & 0.17] & 1.32 \\
mCPP &  & 6 & 0.06 & 0.12 & 0.45 & 0.56 & [-0.18, & 0.29] & 14.41 \\
Overall &  & 20 & 0.06 & 0.07 & 0.74 & 0.33 & [-0.07, & 0.19] & 37.30 \\

\bottomrule\\
% \multicolumn{10}{l}{\multirow{1}{5.63in}{\footnotesize{\emph{Note.}\hspace{.2em} %
\multicolumn{10}{l}{\multirow{1}{5.45in}{\footnotesize{\emph{Note.}\hspace{.2em} %
Heterogeneity test for between-groups prolactin response $Q_B$(3) = 2.12,
$p$ = 0.548 and cortisol response $Q_B$(3) = 2.89, $p$ = 0.408.   $k$ = number of independent effect sizes, $r$ = mean weighted effect size, $SE$ = standard error of the mean weighted effect size, $z$ = critical ratio test for the weighted correlation, $CI$ = 95\% confidence interval, $p$ = two-tailed probability of $z$, $Q_W$ = within-groups heterogeneity.
}}}\\\end{tabular}

